Skip to main content

Crohn's & Colitis
blogs, news & research


IBD therapies not linked with adverse pregnancy outcomes

In this exclusive video, Uma Mahadevan, MD, from the University of California, San Francisco, discusses the results of the PIANIO Study, which explores outcomes of pregnant women with inflammatory bowel disease and their children.

Click for Video Link

She said they found no association between biologic, thiopurine or combination therapy and adverse outcomes at birth or within the first year of life. Additionally, she said physicians should continue providing IBD medication throughout pregnancy.

Posted on: December 22 2020

Leave a comment

Your email address will not be published. Required fields are marked *

No comments found.

About the author

Crohns & Colitis